GripAble key facts
as of Oct 2026- Developer of a remote monitoring device designed to offer assessment and training of hand functions.
- GripAble is valued at approximately $21.3M as of Oct 2026 (last reported valuation).
- It has raised $26.6M across 1 recorded rounds; the latest was Seed Round ($2.7M) in Mar 2026.
- Notable investors include Innovate UK, Parkwalk Advisors, Imperial College London Endowment, IP Group, Imperial College London — 8 tracked in total.
- GripAble has filed 1 Form D with the SEC, most recently Apr 2026 ($2.7M sold to 20 investors).
- Status: Privately Held (backing).
GripAble's last reported valuation, Nov 2023. Nothing priced has surfaced since.
- ·Watch GripAble: the Monday email on marks, rounds and moves
GripAble funding rounds
1 roundsGripAble valuation
GripAble's last reported valuation was $21.3 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has GripAble raised?
GripAble has raised $26.6 million in total; 1 of its rounds is on record. The largest on record was a $2.7 million seed round in Mar 2026.
GripAble has filed 1 Form D with the SEC, most recently in Apr 2026 ($2.7 million sold to 20 investors).
GripAble investors
8 investors are on record for GripAble, including Innovate UK, Parkwalk Advisors, Imperial College London Endowment and IP Group. The seed round in Mar 2026 drew 20 investors.
About GripAble
Developer of a remote monitoring device designed to offer assessment and training of hand functions. The company's device improves the rehabilitation of patients suffering from movement and cognitive disabilities through a combination of hardware, data, and video games in a non-gaming context, enabling people to access engaging training activities that focus on different aspects of grip, hand, and wrist movement.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 18
- Website
- gripable.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.